The potential for biological control of stoats (Mustela erminea)

Abstract

Accelerating the mortality of stoats (Mustela erminea) using biological agents, or reducing their fertility using chemosterilants or biological agents, are increasingly seen as more sustainable and more humane than trapping and poisoning. Obligate delayed implantation in fertilised female stoats of all ages allows 10–11 months for an applied biological agent or chemosterilant to interfere with gestation. Two chemosterilants (cabergoline and mifepristone) disrupt pregnancy in some species and may be effective on stoats, although they are not species‐specific and are probably more expensive than poisoning. For the longer term, more recent fertility control research has explored potentially more species‐specific options for other species based on inducing an immune response to an animal's own reproductive hormones, gametes, or products from embryos. Conception will be difficult to disrupt in stoats because females are sexually mature and are mated in the nest during a short period before they are weaned. A large research effort will be required to determine which of the immunosterilants being developed could be suitable candidates for stoat control. There are fewer options apparent for using biological agents to increase stoat mortality, although species‐specific strains of canine distemper virus may be effective against stoats.

The greatest impediment to controlling stoat fertility will be effective delivery of sterilants. For the foreseeable future, it will probably be necessary to rely on baits, but they are unlikely to put all target stoats at risk, and will be incapable of delivery over larger scales than at present.

Before undertaking expensive field trials and development of anti‐fertility and biological agents, the effects of putative compensatory changes in demographics that may be associated with changes in stoat density should be modelled to see if the sterilisation and mortality rates that are required to achieve a given level of population control are realistic targets. Also, population control should be defined in terms of accrued benefit for wildlife by establishing the relationships between stoat densities and the viability of prey populations.

Biological control of fertility or mortality may never be suitable as stand‐alone control options for stoats, particularly when some native fauna survive only if stoats are reduced to very low densities. Biological control may have greater potential when integrated with conventional control.     

Preliminary Findings of Fecal Gonadal Hormone Concentrations in Six Captive Sea Otters (Enhydra lutris) after Deslorelin Implantation

The sea otter (Enhydra lutris) is a popular exhibit animal in many zoos and aquariums worldwide. Captive sea otters from these populations are owned by the United States Fish and Wildlife Service (USFWS). The USFWS has requested that these sea otters be prevented from breeding in order to save captive space for wild rescued animals. Sea otters are often housed in mixed sex groups, therefore a chemical contraceptive method or surgical removal of gonads must be used to prevent potential pregnancy. The contraceptive, Suprelorin® or deslorelin, has been used in many different species to effectively suppress reproduction but duration of effect may vary not only between species but also individuals. Here, we report the effects of one to several consecutive deslorelin implants on gonadal reproductive hormones found in fecal samples from six captive sea otters (two males and four females) compared to two control otters (one male and one female) housed at three zoological institutions. We documented the longitudinal hormone signatures of many stages of the contraceptive cycle including pretreatment (PT), stimulatory phase (S), effective contraception (EC), and hormone reversal (HR) that was characterized by a return to normal hormone levels. Deslorelin was found to be an effective contraceptive in sea otters and was found to be reversible documented by a live birth following treatment, however the duration of suppression in females was much longer than expected with a 6‐month and a 1‐year implant lasting between 3 and 4 years in females. Zoo Biol. 32:307–315, 2013. © 2012 Wiley Periodicals, Inc.     

Restoration of reproductive potential after expiration or removal of melengestrol acetate contraceptive implants in Tigers (Panthera tigris)

The need for contraception in the successful management of captive wild animals is becoming increasingly apparent. Because concerns exist regarding the reversibility of the contraceptive implant melengestrol acetate (MGA), reproductive data for 94 female Amur (Panthera tigris altaica) and Sumatran tigers (Panthera tigris sumatrae) were analyzed using survival analyses to evaluate return to reproductive status after implant removal or assumed expiration. Females placed in potential breeding situations after MGA implants were surgically removed showed a 62% return to reproduction by 5.25 years, whereas females with implants that were assumed to have expired showed only a 30% return to reproduction by 6 years. Implanted females did not reproduce as successfully as non‐implanted control females, which showed an 85% probability of reproducing after placement in a new breeding situation by 2.66 years. Parturition increased the probability of reproducing in non‐implanted females, but not in implanted females. Litter size, stillbirths, and offspring survival were not significantly different between non‐implanted, implant‐removed and implant‐expired female tigers. Ten female tigers reproduced both before and after implant placement, and the differences in litter size, stillbirths, and offspring survival were not significant, nor were they significantly different from non‐implanted females. Prior parturition, age when implant was removed, and duration of implantation did not affect the probability of reproducing for females after implant removal. These results show substantial reversibility of MGA implants, leading to 62% successful reproduction after implant removal. The reasons for lower successful reproduction in animals previously treated with the contraceptive compared to non‐implanted females are not known, but a greater delay in reversibility was seen when implants were left in place and only presumed expired. Zoo Biol 26:275–288, 2007. © 2007 Wiley‐Liss, Inc.     

Reproductive cycles and contraception of black lemurs (Eulemur macaco macaco) with depot medroxyprogesterone acetate during the breeding season

Contraception is a critical component of population management for lemurs, but concerns about potential deleterious effects of continuous, long‐term treatment with synthetic progestins such as the widely used melengestrol acetate implant led us to evaluate seasonal contraception with injections of depot medroxyprogesterone acetate (Depo‐Provera, Upjohn Pharmacia, Kalamazoo, MI) to limit the duration of exposure. We compared two dosage regimens in female black lemurs using vaginal cytology as an indirect measure of ovarian suppression. Our results indicate that both 10 mg/kg body weight at 90‐day intervals or 2.5 mg/kg at approximately 30‐day intervals can be effective in most females, although one female on the 10‐mg dose showed signs of estrus at 53 days. Darkening of pelage during treatment was the primary side effect noted. A more important observation was that contraception can extend the breeding season to as much as 9 months, considerably longer than reported previously, which necessitates extending the period of contraceptive treatment. Zoo Biol 26:289–298, 2007. © 2007 Wiley‐Liss, Inc.     

Evaluating reproductive decisions as discrete choices under social influence

Discrete choice, coupled with social influence, plays a significant role in evolutionary studies of human fertility, as investigators explore how and why reproductive decisions are made. We have previously proposed that the relative magnitude of social influence can be compared against the transparency of pay-off, also known as the transparency of a decision, through a heuristic diagram that maps decision-making along two axes. The horizontal axis represents the degree to which an agent makes a decision individually versus one that is socially influenced, and the vertical axis represents the degree to which there is transparency in the pay-offs and risks associated with the decision the agent makes. Having previously parametrized the functions that underlie the diagram, we detail here how our estimation methods can be applied to real-world datasets concerning sexual health and contraception.     

Making family planning accessible in resource-poor settings

It is imperative to make family planning more accessible in low resource settings. The poorest couples have the highest fertility, the lowest contraceptive use and the highest unmet need for contraception. It is also in the low resource settings where maternal and child mortality is the highest. Family planning can contribute to improvements in maternal and child health, especially in low resource settings where overall access to health services is limited. Four critical steps should be taken to increase access to family planning in resource-poor settings: (i) increase knowledge about the safety of family planning methods; (ii) ensure contraception is genuinely affordable to the poorest families; (iii) ensure supply of contraceptives by making family planning a permanent line item in healthcare system''s budgets and (iv) take immediate action to remove barriers hindering access to family planning methods. In Africa, there are more women with an unmet need for family planning than women currently using modern methods. Making family planning accessible in low resource settings will help decrease the existing inequities in achieving desired fertility at individual and country level. In addition, it could help slow population growth within a human rights framework. The United Nations Population Division projections for the year 2050 vary between a high of 10.6 and a low of 7.4 billion. Given that most of the growth is expected to come from today''s resource-poor settings, easy access to family planning could make a difference of billions in the world in 2050.     

Women's evaluations of other women's natural body odor depend on target's fertility status

A large research literature indicates that men perceive women as more attractive when they are at high fertility than at low fertility within the ovulatory cycle. However, it remains unclear whether women also perceive women as more attractive at high fertility. This study examined women's ratings of samples of natural body odor collected from naturally-cycling women at high and low fertility within the cycle and from hormonal contraceptive-using women at mid-cycle. Like men, women rated naturally-cycling women's high-fertility scent samples as more attractive than their low-fertility samples. Women rated hormonal contraceptive (HC) users' scent samples as more attractive than naturally-cycling women's high- and low-fertility samples, though the difference between HC and high-fertility samples was statistically significant only when raters were treated as the unit of analysis. These findings reveal a potentially important role for scent communication in women's perceptions of other women and are consistent with the notion that the ovulatory cycle could influence women's interactions with one another. The findings also highlight the need for rigorous investigations of the possible impacts of hormonal contraception on women's attractiveness and social relationships with other women.     

Reversibility of germinative and endocrine testicular function after long-term contraception with a GnRH-agonist implant in the tom—a follow-up study

A significantly reduced gonadotropin and testosterone secretion is a well-described result of long-term administration of GnRH agonists in the male dog and cat. To date, no data are available about the duration of efficacy and the reversibility of treatment-induced effects after long-term treatment with a 4.7 mg deslorelin implant. Seven healthy male European Shorthair cats (3.2 ± 0.5 kg, 1–6 years) were treated with a 4.7 mg deslorelin implant. Blood samples (testosterone, T), testicular volume, penile spines, and mating behavior were recorded once weekly. Considering T > 0.5 ng/mL as the biological endpoint, mean duration of efficacy was 78.8 ± 12.9 weeks (range: 61.7–100.7 weeks) with T concentrations increasing rapidly after the last T less than 0.1 ng/mL (basal) (P < 0.0001), and pretreatment T concentrations being reached after 3 weeks. Testicular volume rapidly increased after the first increase of T (P < 0.001) with pretreatment testicular volume being reached after 6.9 ± 3.4 weeks (5–11 weeks). “Normal” libido reoccurred 88.7 ± 12.4 weeks after treatment, and “normal” mating behavior was observed even later. Fertile matings occurred 7 to 42 weeks after the last T less than 0.1 ng/mL with a mean of 4.0 ± 0.0 kittens, and 13.6 to 47.6 weeks afterwards testicular histology revealed normal spermatogenesis. The present data confirm that the use of slow-release GnRH-agonist implants containing deslorelin in tomcats represents an effective and safe reversible alternative for long-term contraception; however, as number of animals is low, further fertility trials are recommended.     

Diagnosis and prevalence of uterine leiomyomata in female chimpanzees (Pan troglodytes)

Uterine leiomyomata are common, affecting 70-80% of women between 30 and 50 years of age. Leiomyomata have been reported for a variety of primate species, although prevalence rates and treatments have not been widely reported. The prevalence, diagnosis, and treatment of uterine leiomyomata in the Alamogordo Primate Facility and the Keeling Center for Comparative Medicine and Research were examined. Uterine leiomyomata were diagnosed in 28.4% of chimpanzees with an average age at diagnosis of 30.4 ± 8.0 years. Advanced age (>30 years) was related to an increase in leiomyomata and use of hormonal contraception was related to a decrease in leiomyomata. As the captive chimpanzee population ages, the incidence of leiomyomata among female chimpanzees will likely increase. The introduction of progesterone-based contraception for nonbreeding research and zoological chimpanzees may reduce the development of leiomyomata. Finally, all chimpanzee facilities should institute aggressive screening programs and carefully consider treatment plans.